INVEGA TRINZA
Active substance: paliperidone palmitate
INJECTION, SUSPENSION, EXTENDED RELEASE · PALIPERIDONE PALMITATE 546 mg/1.75mL
United StatesActive
Marketing holder: Janssen Pharmaceuticals, Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PALIPERIDONE PALMITATE · 546 mg/1.75mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 4 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2b81-7ce2-a793-78d45b9c0ea2,01a1208c-6c63-7088-997d-f7e8798e4a97,01a1208f-09ad-759b-ba56-b52d3142edcf,01a12090-e33e-77fc-8f70-d0332ec054bc,01a12091-b7f6-7c51-bbe8-8d1650b1fd68;count=17 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50458-608
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR
Sources
- product · openFDA NDC · 50458-608 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50458-608 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50458-608 · Verified 2026-10-09 · open in source